Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Abstract 832: Breast cancer plasticity is restricted by a LATS1-NCOR1 repressive function

Yael Aylon, Noa Furth, Giuseppe Mallel, Nishanth Nataraj, Gilgi Friedlander, Ori Hassan, Rawan Zoabi, Benjamin Cohen, Tomer Salame, Saptaparna Mukherjee, Randy Johnson, Efrat Shema, Moshe Oren

Cancer Res (2022) 82 (12_Supplement): 832.

https://doi.org/10.1158/1538-7445.AM2022-832

Published: 15 June 2022

View article titled, Abstract 832: Breast cancer plasticity is restricted by a LATS1-NCOR1 repressive function

Journal Articles

Abstract 5288: Development of lead mutant-p53 reactivating peptides towards clinical application

Perry Tal, Moshe Oren, Orna Palgi, Varda Rotter, KWANGIL JEONG

Cancer Res (2022) 82 (12_Supplement): 5288.

https://doi.org/10.1158/1538-7445.AM2022-5288

Published: 15 June 2022

View article titled, Abstract 5288: Development of lead mutant-p53 reactivating peptides towards clinical application

Journal Articles

A Division of Labor between YAP and TAZ in Non–Small Cell Lung Cancer

Michal Shreberk-Shaked, Bareket Dassa, Sanju Sinha, Silvia Di Agostino, Ido Azuri, Saptaparna Mukherjee, Yael Aylon, Giovanni Blandino, Eytan Ruppin, Moshe Oren

Cancer Res (2020) 80 (19): 4145–4157.

https://doi.org/10.1158/0008-5472.CAN-20-0125

Published: 02 October 2020

View article titled, A Division of Labor between YAP and TAZ in Non–Small Cell Lung Cancer

Includes: Supplementary data

Journal Articles

Abstract 4320: Ovarian cancer persister cells are characterized by enhanced ER stress gene expression correlating with poor survival

Kathrin Böpple, Meng Dong, Markus Kleih, Andrea Gaißler, Yaara Oren, Whitney S. Henry, Moshe Oren, Yael Aylon, Bernd Winkler, Aviv Regev, Robert A. Weinberg, Hans-Georg Kopp, Walter E. Aulitzky, Frank Essmann

Cancer Res (2020) 80 (16_Supplement): 4320.

https://doi.org/10.1158/1538-7445.AM2020-4320

Published: 15 August 2020

View article titled, Abstract 4320: Ovarian cancer persister cells are characterized by enhanced ER stress gene expression correlating with poor survival

Journal Articles

Abstract SY32-02: Modulation of wild-type p53 activity in cancer cells and in the tumor microenvironment

Moshe Oren, Sharathchandra Arandkar, Gal Benor, Noa Furth, Yael Aylon, Eytan Domany

Cancer Res (2019) 79 (13_Supplement): SY32-02.

https://doi.org/10.1158/1538-7445.AM2019-SY32-02

Published: 01 July 2019

View article titled, Abstract SY32-02: Modulation of wild-type p53 activity in cancer cells and in the tumor microenvironment

Journal Articles

Abstract 2372: Tumoral p53 mutations differentially mediate poor T-cell infiltration and autologous T-cell killing in preclinical models

Deborah A. Silverman, Emily Ashkin, Benjamin Whitfield, Simone Punt, Soraya Zorro Manrique, Yunfei Wang, Anil Korkut, Leila Williams, Minying Zhang, Eran Kotler, Moshe Oren, Anirban Maitra, Patrick Hwu

Cancer Res (2019) 79 (13_Supplement): 2372.

https://doi.org/10.1158/1538-7445.AM2019-2372

Published: 01 July 2019

View article titled, Abstract 2372: Tumoral p53 mutations differentially mediate poor T-cell infiltration and autologous T-cell killing in preclinical models

Journal Articles

Retraction: Transactivation of the EGR1 Gene Contributes to Mutant p53 Gain of Function

Lilach Weisz, Amir Zalcenstein, Perry Stambolsky, Yehudit Cohen, Naomi Goldfinger, Moshe Oren, Varda Rotter

Cancer Res (2019) 79 (8): 2085.

https://doi.org/10.1158/0008-5472.CAN-19-0560

Published: 15 April 2019

View article titled, Retraction: Transactivation of the <em>EGR1</em> Gene Contributes to Mutant p53 Gain of Function

Journal Articles

Early Loss of Histone H2B Monoubiquitylation Alters Chromatin Accessibility and Activates Key Immune Pathways That Facilitate Progression of Ovarian Cancer

Jagmohan Hooda, Marián Novak, Matthew P. Salomon, Chikako Matsuba, Romela I. Ramos, Emily MacDuffie, Melissa Song, Michelle S. Hirsch, Jenny Lester, Vinita Parkash, Beth Y. Karlan, Moshe Oren, Dave S. Hoon, Ronny Drapkin

Cancer Res (2019) 79 (4): 760–772.

https://doi.org/10.1158/0008-5472.CAN-18-2297

Published: 15 February 2019

View article titled, Early Loss of Histone H2B Monoubiquitylation Alters Chromatin Accessibility and Activates Key Immune Pathways That Facilitate Progression of Ovarian Cancer

Includes: Supplementary data

Journal Articles

Abstract SY26-03: Tumor suppressor crosstalk: Modulation of p53 activity by the Hippo pathway

Moshe Oren, Noa Furth, Noa Bossel Ben-Moshe, Ziv Porat, Eytan Domany, Yair Pozniak, Tamar Geiger, Yael Aylon

Cancer Res (2016) 76 (14_Supplement): SY26-03.

https://doi.org/10.1158/1538-7445.AM2016-SY26-03

Published: 15 July 2016

View article titled, Abstract SY26-03: Tumor suppressor crosstalk: Modulation of p53 activity by the Hippo pathway

Journal Articles

Abstract 1721: Testicular germ cell tumors are hypersensitive to p53 activation based on their Oct-4/Noxa-mediated cellular context rather than on differential p53 activity.

Matthias Gutekunst, Thomas Mueller, Andrea Weilbacher, Michael A. Dengler, Moshe Oren, Walter E. Aulitzky, Heiko van der Kuip

Cancer Res (2013) 73 (8_Supplement): 1721.

https://doi.org/10.1158/1538-7445.AM2013-1721

Published: 15 April 2013

View article titled, Abstract 1721: Testicular germ cell tumors are hypersensitive to p53 activation based on their Oct-4/Noxa-mediated cellular context rather than on differential p53 activity.

Journal Articles

Cisplatin Hypersensitivity of Testicular Germ Cell Tumors Is Determined by High Constitutive Noxa Levels Mediated by Oct-4

Matthias Gutekunst, Thomas Mueller, Andrea Weilbacher, Michael A. Dengler, Jens Bedke, Stephan Kruck, Moshe Oren, Walter E. Aulitzky, Heiko van der Kuip

Cancer Res (2013) 73 (5): 1460–1469.

https://doi.org/10.1158/0008-5472.CAN-12-2876

Published: 03 March 2013

View article titled, Cisplatin Hypersensitivity of Testicular Germ Cell Tumors Is Determined by High Constitutive Noxa Levels Mediated by Oct-4

Includes: Supplementary data

Journal Articles

Cancer Cells Cue the p53 Response of Cancer-Associated Fibroblasts to Cisplatin

Jens O. Schmid, Meng Dong, Silke Haubeiss, Godehard Friedel, Sabine Bode, Andreas Grabner, German Ott, Thomas E. Mürdter, Moshe Oren, Walter E. Aulitzky, Heiko van der Kuip

Cancer Res (2012) 72 (22): 5824–5832.

https://doi.org/10.1158/0008-5472.CAN-12-1201

Published: 14 November 2012

View article titled, Cancer Cells Cue the p53 Response of Cancer-Associated Fibroblasts to Cisplatin

Includes: Supplementary data

Journal Articles

Abstract 2869: p53 response of cancer associated fibroblasts (CAFs) to cisplatin is closely correlated with the p53 response of tumor cells in lung cancer tissue cultures

Jens O. Schmid, Meng Dong, Silke Haubeiss, Godehard Friedel, Moshe Oren, Thomas E. Mürdter, Walter E. Aulitzky, Heiko van der Kuip

Cancer Res (2012) 72 (8_Supplement): 2869.

https://doi.org/10.1158/1538-7445.AM2012-2869

Published: 15 April 2012

View article titled, Abstract 2869: p53 response of cancer associated fibroblasts (CAFs) to cisplatin is closely correlated with the p53 response of tumor cells in lung cancer tissue cultures

Journal Articles

Consistency Test of the Cell Cycle: Roles for p53 and EGR1

Yaara Zwang, Moshe Oren, Yosef Yarden

Cancer Res (2012) 72 (5): 1051–1054.

https://doi.org/10.1158/0008-5472.CAN-11-3382

Published: 01 March 2012

View article titled, Consistency Test of the Cell Cycle: Roles for p53 and EGR1

Journal Articles

Abstract 4693: High expression levels of NOXA are important for p53-mediated hypersensitivity in testicular germ cell tumor (TGCT) cells

Matthias Gutekunst, Moshe Oren, Andrea Weilbacher, Michael A. Dengler, Walter E. Aulitzky, Heiko van der Kuip

Cancer Res (2011) 71 (8_Supplement): 4693.

https://doi.org/10.1158/1538-7445.AM2011-4693

Published: 15 April 2011

View article titled, Abstract 4693: High expression levels of NOXA are important for p53-mediated hypersensitivity in testicular germ cell tumor (TGCT) cells

Journal Articles

p53 Status in Stromal Fibroblasts Modulates Tumor Growth in an SDF1-Dependent Manner

Yoseph Addadi, Neta Moskovits, Dorit Granot, Guillermina Lozano, Yaron Carmi, Ron N. Apte, Michal Neeman, Moshe Oren

Cancer Res (2010) 70 (23): 9650–9658.

https://doi.org/10.1158/0008-5472.CAN-10-1146

Published: 06 December 2010

View article titled, p53 Status in Stromal Fibroblasts Modulates Tumor Growth in an SDF1-Dependent Manner

Includes: Supplementary data

Journal Articles

Imatinib Mesylate Induces Cisplatin Hypersensitivity in Bcr-Abl⁺ Cells by Differential Modulation of p53 Transcriptional and Proapoptotic Activity

Ioanna Skorta, Moshe Oren, Christiane Markwardt, Matthias Gutekunst, Walter E. Aulitzky, Heiko van der Kuip

Cancer Res (2009) 69 (24): 9337–9345.

https://doi.org/10.1158/0008-5472.CAN-09-0548

Published: 14 December 2009

View article titled, Imatinib Mesylate Induces Cisplatin Hypersensitivity in Bcr-Abl<sup>+</sup> Cells by Differential Modulation of p53 Transcriptional and Proapoptotic Activity

Includes: Supplementary data

Journal Articles

Abstract #862: Imatinib mesylate modulates p53 transcriptional and apoptotic activities selectively in Bcr-Abl positive cells and thereby sensitizes CML cells to Cisplatin

Ioanna Skorta, Silke Fanta, Silke Haubeiß, Christiane Markwardt, Moshe Oren, Walter Aulitzky, Heiko van der Kuip

Cancer Res (2009) 69 (9_Supplement): 862.

Published: 01 May 2009

View article titled, Abstract #862: Imatinib mesylate modulates p53 transcriptional and apoptotic activities selectively in Bcr-Abl positive cells and thereby sensitizes CML cells to Cisplatin

Journal Articles

Mutant p53 Enhances Nuclear Factor κB Activation by Tumor Necrosis Factor α in Cancer Cells

Lilach Weisz, Alexander Damalas, Michalis Liontos, Panagiotis Karakaidos, Giulia Fontemaggi, Revital Maor-Aloni, Marina Kalis, Massimo Levrero, Sabrina Strano, Vassilis G. Gorgoulis, Varda Rotter, Giovanni Blandino, Moshe Oren

Cancer Res (2007) 67 (6): 2396–2401.

https://doi.org/10.1158/0008-5472.CAN-06-2425

Published: 15 March 2007

View article titled, Mutant p53 Enhances Nuclear Factor κB Activation by Tumor Necrosis Factor α in Cancer Cells

Includes: Supplementary data

Journal Articles

p53 Attenuates Cancer Cell Migration and Invasion through Repression of SDF-1/CXCL12 Expression in Stromal Fibroblasts

Neta Moskovits, Alexander Kalinkovich, Jair Bar, Tsvee Lapidot, Moshe Oren

Cancer Res (2006) 66 (22): 10671–10676.

https://doi.org/10.1158/0008-5472.CAN-06-2323

Published: 15 November 2006

View article titled, p53 Attenuates Cancer Cell Migration and Invasion through Repression of SDF-1/CXCL12 Expression in Stromal Fibroblasts

NARROW

Abstract 832: Breast cancer plasticity is restricted by a LATS1-NCOR1 repressive function

Abstract 5288: Development of lead mutant-p53 reactivating peptides towards clinical application

A Division of Labor between YAP and TAZ in Non–Small Cell Lung Cancer

Abstract 4320: Ovarian cancer persister cells are characterized by enhanced ER stress gene expression correlating with poor survival

Abstract SY32-02: Modulation of wild-type p53 activity in cancer cells and in the tumor microenvironment

Abstract 2372: Tumoral p53 mutations differentially mediate poor T-cell infiltration and autologous T-cell killing in preclinical models

Retraction: Transactivation of the EGR1 Gene Contributes to Mutant p53 Gain of Function

Early Loss of Histone H2B Monoubiquitylation Alters Chromatin Accessibility and Activates Key Immune Pathways That Facilitate Progression of Ovarian Cancer

Abstract SY26-03: Tumor suppressor crosstalk: Modulation of p53 activity by the Hippo pathway

Abstract 1721: Testicular germ cell tumors are hypersensitive to p53 activation based on their Oct-4/Noxa-mediated cellular context rather than on differential p53 activity.

Cisplatin Hypersensitivity of Testicular Germ Cell Tumors Is Determined by High Constitutive Noxa Levels Mediated by Oct-4

Cancer Cells Cue the p53 Response of Cancer-Associated Fibroblasts to Cisplatin

Abstract 2869: p53 response of cancer associated fibroblasts (CAFs) to cisplatin is closely correlated with the p53 response of tumor cells in lung cancer tissue cultures

Consistency Test of the Cell Cycle: Roles for p53 and EGR1

Abstract 4693: High expression levels of NOXA are important for p53-mediated hypersensitivity in testicular germ cell tumor (TGCT) cells

p53 Status in Stromal Fibroblasts Modulates Tumor Growth in an SDF1-Dependent Manner

Imatinib Mesylate Induces Cisplatin Hypersensitivity in Bcr-Abl⁺ Cells by Differential Modulation of p53 Transcriptional and Proapoptotic Activity

Abstract #862: Imatinib mesylate modulates p53 transcriptional and apoptotic activities selectively in Bcr-Abl positive cells and thereby sensitizes CML cells to Cisplatin

Mutant p53 Enhances Nuclear Factor κB Activation by Tumor Necrosis Factor α in Cancer Cells

p53 Attenuates Cancer Cell Migration and Invasion through Repression of SDF-1/CXCL12 Expression in Stromal Fibroblasts

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only